CYTOKINETICS INC 4
4 · CYTOKINETICS INC · Filed Feb 25, 2016
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
WOLFF ANDREW A
SVP Clinical R&D, CMO
Transactions
- Award
Incentive Stock Option (right to buy)
2016-02-23+18,425→ 18,425 totalExercise: $6.67From: 2016-03-23Exp: 2026-02-23→ Common Stock (18,425 underlying) - Award
Non-Qualified Stock Option (right to buy)
2016-02-23+21,575→ 21,575 totalExercise: $6.67From: 2016-03-23Exp: 2026-02-23→ Common Stock (21,575 underlying)
Footnotes (1)
- [F1]When the ISO and NQ dated 02/23/2016 are combined for a total grant of 40,000 shares, the option shall vest and become exercisable as to 40,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/23/2020.